Report Wire

News at Another Perspective

Uzbekistan claims 18 kids died after ingesting Made in India syrup

2 min read

18 out of 21 kids with acute respiratory illness have died because of taking Doc-1 Max syrup, well being ministry of Uzbekistan stated.

New Delhi,UPDATED: Dec 28, 2022 18:36 IST

Dok-1 Max is manufactured by the Uttar Pradesh-based Marion Biotech. (Image: Marion Biotech)

By India Today Web Desk: Months after the Gambian kids’s loss of life row, the well being ministry of Uzbekistan has claimed that as many as 18 kids have misplaced their lives within the nation after consuming medicines manufactured by an Indian pharmaceutical firm.

The firm in query is Marion Biotech Private Limited, which was registered in 2012 in Uzbekistan.

ALSO READ | Haryana’s Maiden Pharma, firm whose cough syrup killed 66 Gambian children, has a shady previous

In a press release, the well being ministry stated the kids who died had consumed the Dok-1 Max Syrup produced by Noida-based Marion Biotech. To date, 18 out of 21 kids with acute respiratory illness have died because of taking Doc-1 Max syrup, the ministry stated.

“It was found that the deceased children, before admission to hospital treatment, took this drug at home for 2-7 days 3-4 times a day, 2.5-5 ml, which exceeds the standard dose of the drug for children,” the assertion famous.

“Since the main component of the drug is paracetamol, Doc-1 Max syrup was incorrectly used by parents as an anti-cold remedy on their own or on the recommendation of pharmacy sellers. And this was the reason for the deterioration of the condition of patients,” it added.

The preliminary laboratory research have proven that this collection of Doc-1 Max syrup comprises ethylene glycol. “This substance is toxic, and about 1-2 ml/kg of a 95% concentrated solution can cause serious changes in the patient’s health, such as vomiting, fainting, convulsions, cardiovascular problems and acute kidney failure,” the ministry identified.

ALSO READ | Drugs board orders probe after WHO’s alert towards India-made cough syrups

A complete of seven accountable staff had been dismissed from their positions for being negligent and inattentive to their duties and even disciplinary measures had been utilized to a lot of specialists.

Currently, tablets and syrups of the drug Doc-1 Max are withdrawn from sale in all pharmacies of the nation within the prescribed method. The ministry has additionally requested mother and father to be attentive to the well being of their kids, and to buy medicines in pharmacies solely by prescription.

This comes months after the World Health Organization (WHO) issued an alert for 4 “contaminated” cough syrups manufactured by an Indian drugmaker, Maiden Pharma, which were “potentially linked” with acute kidney accidents and 66 deaths amongst kids in Gambia.

Published On:

Dec 28, 2022